论文部分内容阅读
我们采用丹参注射液治疗门脉性肝硬化失偿患者45例,男41例,女4例,平均52.2岁,对照组(能量合剂组)30例,男27例,女3例,平均51.5岁。全部病历B超检查均有腹水、脾大、门静脉增宽,肝功能异常。治疗组采用丹参注射液10ml加入10%葡萄糖250ml静滴,每日1次,4周为一疗程,治疗前和一疗程后B超观察腹水,测脾厚度和门静脉宽度(内径)。治疗4周后结果,治疗组脾厚度缩小显效11例占24.4%,有效13例占28.9%,
We use Danshen injection in patients with portal vein cirrhosis compensation for 45 patients, 41 males and 4 females, mean 52.2 years, the control group (energy mixture group) 30 cases, 27 males and 3 females, mean 51.5 years . All medical records B-ascites, splenomegaly, portal vein widening, abnormal liver function. In the treatment group, 10ml Danshen injection was added to 250ml intravenous infusion of 10% glucose once a day for 4 weeks for one course of treatment. Before treatment and after a course of treatment, B-ascites were observed, splenic thickness and portal vein width (ID) were measured. After 4 weeks of treatment, the spleen thickness decreased significantly in treatment group, 11 cases accounted for 24.4%, effective 13 cases accounted for 28.9%